BIRTCHER MEDICAL SYSTEMS' NEW PRESIDENT, CEO KENNETH CLEVELAND
This article was originally published in The Gray Sheet
Executive Summary
BIRTCHER MEDICAL SYSTEMS' NEW PRESIDENT, CEO KENNETH CLEVELAND brings turnaround management experience to his new job at the struggling Irvine, California-based company. Effective May 17, Cleveland took the helm at Birtcher "to lead the significantly streamlined company back to profitability." He previously headed up three other California companies that he guided out of the red: flow control device manufacturer Tylan, autoparts distributor Cardis and electronics components company Mica. Cleveland is president of Kenneth Cleveland Associates Inc.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.